Advertisement

Drug Facts | DiabetiDerm Antifungal

16:29 EDT 22nd May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Undecylenic Acid 10%

Antifungal

For external use only.

do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

irritation occurs or if there is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch).

If swallowed, get medical help or contact a Poison Control Center right away.

Aloe Vera, Arginine, Cetyl Alcohol, Clotrimazole, Coco-Caprylate/Caprate, Disodium EDTA, Glyceryl Stearate, Lavender Oil, Methylparaben, Ornithine HCl, PEG-100 Stearate, Propylparaben, Sodium Polyacrylate, Sorbitan Stearate, Stearic Acid, Tea Tree Oil, Triethanolamine, Urea, Water.

Call: 1-800-899-3116, Mon-Thurs 9:00 am - 5:00 pm EST, Fri 9:00 am - 2:30 pm EST. Serious side effects associated with use of this product may be reported to this number.

Rev. 481:02 4/11

 PODIATRIST RECOMMENDED

DiabetiDerm Antifungal Cream

contains Undecylenic Acid 10% and

L-Arginine HCl

KILLS TOENAIL & FOOT FUNGUS

NET WT 1.5 OZ (42 g)

IMAGE a32eafa4-0c4f-4c62-a00b-33066572514a-01.jpg

Manufacturer

avVaa World Health Care Products

Active Ingredients

Source

Drugs and Medications [ 190 Associated Drugs and Medications listed on BioPortfolio]

3m cavilon antifungal [3M Health Care]

Cavilon™Antifungal Cream

Antifungal [Dynarex Corporation]

Antifungal Cream

Clotrimazole [Kinray Inc.]

Antifungal

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

Clotrimazole [Taro Pharmaceuticals, Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

Clinical Trials [ 66 Associated Clinical Trials listed on BioPortfolio]

Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy

The primary purpose of this protocol is to provide fluconazole for the treatment of individual patients who require therapy for serious or life-threatening systemic fungal infection, who h...

Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

Susceptibility testing is commonly employed in patients with bacterial infections in order to guide rational use of antibiotics; however, the use of antifungal susceptibility testing is li...

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Patients who undergo chemotherapy for leukemia will recieve an antifungal intravenously for prophylaxis of fungal infections. The study investigates the safet and tolerability of two diffe...

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

The purpose of this study is to determine whether stopping preventive histoplasmosis medications in patients who are currently receiving effective anti-HIV drugs will place them at risk fo...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

PubMed Articles [ 905 Associated PubMed Articles listed on BioPortfolio]

Synthesis and antifungal activity of benzofuran-5-ols.

Benzofuran-5-ol derivatives were synthesized and tested for in vitro antifungal activity against Candida, Aspergillus species, and Cryptococcus neoformans. Among them tested, many benzofuran-5-ols sho...

New Lead Structures in Antifungal Drug Discovery.

During the past two decades, the incidence of invasive fungal infections has been increasing dramatically. Clinical available antifungal agents have several drawbacks such as limited potency and spect...

Synthesis and Biological Evaluation of Antifungal Activities of Novel 1,2-trans Glycosphingolipids.

The synthesis and in-vitro biological evaluation of antifungal activities of a series of 1,2-trans glycosphingolipids (GSL) against Candida albicans, Candida parapsilosis, and Candida tropicalis were...

Synthesis and antifungal activity of 1-thia-4b-aza-cyclopentabfluorene-4,10-diones.

1-Thia-4b-aza-cyclopenta[b]fluorene-4,10-diones were synthesized and tested for in vitro antifungal activity against two pathogenic strains of fungi. Among them tested, many compounds showed good anti...

Antifungal Nanoparticles and Surfaces.

Nosocomial fungal infections, an increasing healthcare concern worldwide, are often associated with medical devices. We have developed antifungal nanoparticle conjugates that can act in suspension or...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement